Prelude Therapeutics PRLD
NASDAQ PRLD
$3.91 -0.05 (-1.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Shares Outstanding (Entity) (2019 - 2026)

Updated

Prelude Therapeutics (PRLD) posted Shares Outstanding (Entity) of 79.8 million for Q2 2026, up 5.0% from 75.99 million a year earlier and up 0.2% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, Prelude Therapeutics' Shares Outstanding (Entity) came in at 63 million, down 16.9% from FY2024.

  • Annual Shares Outstanding (Entity) shows a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
  • In prior years, Prelude Therapeutics' Shares Outstanding (Entity) was 75.81 million in FY2024 (+38.0%), 54.92 million in FY2023 (+14.6%), 47.91 million in FY2022 (+0.6%) and 47.63 million in FY2021 (+281.7%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2019.
  • On a year-over-year basis, Shares Outstanding (Entity) increased in six of the last eight quarters, with growth averaging 6.6%.
  • The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q4 2021, with growth of 281.7%; the weakest was Q3 2025, with a decline of 17.1%.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 79.65 million (Q1 2026), 63 million (Q4 2025) and 62.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 79.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.80 Mn
Mar 31, 2026 79.65 Mn
Dec 31, 2025 63.00 Mn
Sep 30, 2025 62.87 Mn
Jun 30, 2025 75.99 Mn
Mar 31, 2025 75.99 Mn
Dec 31, 2024 75.81 Mn
Sep 30, 2024 75.86 Mn
Jun 30, 2024 75.76 Mn
Mar 31, 2024 75.74 Mn
Dec 31, 2023 54.92 Mn
Sep 30, 2023 54.83 Mn
Jun 30, 2023 54.81 Mn
Mar 31, 2023 47.96 Mn
Dec 31, 2022 47.91 Mn
Sep 30, 2022 47.86 Mn
Jun 30, 2022 47.83 Mn
Mar 31, 2022 47.70 Mn
Dec 31, 2021 47.63 Mn
Sep 30, 2021 47.22 Mn
API Access

Prelude Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PRLD&period=max&api_key=YOUR_API_KEY